Reduction of migrainous headaches during the use of acenocoumarol

Headache

Volumn 36, Issue 1, 1996, Pages 48-

  Van Puijenbroek, E P ^a,b   Egberts, A C G ^a   Trooster, J F G ^c   Zomerdijk, J ^c  

^a LAREB   (Netherlands)

^b NONE   (Netherlands)

^c NONE

Author keywords

acenocoumarol; migraine

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIMIGRAINE AGENT; ANTIVITAMIN K; CALCIUM CARBONATE; ETIDRONIC ACID; HEPARIN; PROPRANOLOL; SIMVASTATIN; SUMATRIPTAN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DRUG MECHANISM; FEMALE; GERIATRIC PATIENT; HUMAN; MIGRAINE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE AGGREGATION; TOTAL HIP PROSTHESIS;

EID: 0030046292     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3601048.x     Document Type: Article

References (5)

1. Behnen HJ. Migräne und Marcumar. Dtsch Med Wochenschr. 1979;104:32-33.
2. Suresh CG, Neal D, Coupe MO. Warfarin treatment and migraine. Postgrad Med J. 1994;70:37-38.
3. Thonnard-Neumann E. Migraine therapy with heparin: pathophysiologic basis. Headache. 1977;16:284-292.
4. Couch JR, Hassanein RS. Platelet aggregability in migraine. Neurology. 1977;27:843-848.
5. Deshmukh SV, Meyer JS. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine. Headache. 1977;17:101-108.